At a glance
- Originator Taisho Pharmaceutical
- Class Amidines; Antiplatelets; Thiazoles; Vascular disorder therapies
- Mechanism of Action GPIIb-IIIa antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis; Thrombosis
Most Recent Events
- 13 Aug 1998 New profile
- 13 Aug 1998 Phase-I clinical trials for Coronary artery restenosis in Japan (Unknown route)
- 13 Aug 1998 Phase-I clinical trials for Thrombosis in Japan (Unknown route)